“The American president wants to force the industry to lower the cost of medical treatment in the United States. The pharmaceutical sector could respond by increasing its prices in Europe or delaying the launch of innovative treatments.”

Emmanuelle Trombe comments in Le Monde. Click here to read the full article (in French via paywall).